Tag: stage IIB/C melanoma treatment

Home / stage IIB/C melanoma treatment

Categories

Nivolumab is approved by the FDA for adjuvant treatment of Stage IIB/C melanoma

Nov 2023: Nivolumab (Opdivo, Bristol-Myers Squibb Company) was granted approval by the Food and Drug Administration as an adjuvant therapy for Stage IIB/C melanoma in patients 12 years of age and ol...
stage-iib-c-melanoma-treatment

We Are Online! Chat With Us!
Scan the code